Physician
Pediatric & Adolescent Advance Care PLLC
Pediatric & Adolescent Advance Care PLLC was paid $10.12M by Medicaid between Jan 2018 and Dec 2024, across 107 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoPEDIATRIC & ADOLESCENT ADVANCE CARE PLLC
FLINT, MI 48532
FLINT, MI 48532
33aNPI1093159105assigned 04/18/2013
33bProvider typePediatrics Physician
28Total paid$10.12M
24GClaims644,715
24DCodes billed107
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Michigan
Rank by total paid#4 of 349
Median peer was paid$321K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,504 | $476K | |
| 2019 | 43,625 | $856K | |
| 2020 | 63,213 | $772K | |
| 2021 | 85,364 | $1.18M | |
| 2022 | 136,370 | $1.94M | |
| 2023 | 146,263 | $2.26M | |
| 2024incomplete | 153,376 | $2.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 48,322 | 37,180 | $4.71M |
| D0190 | 7.0% | 46,967 | 37,818 | $712K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 7,448 | 7,351 | $631K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.2% | 7,336 | 5,653 | $528K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.0% | 7,009 | 6,384 | $505K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 4,053 | 4,034 | $338K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 2,787 | 2,778 | $335K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 10,298 | 9,569 | $294K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.8% | 2,787 | 2,593 | $287K |
| 87631 | 2.8% | 2,614 | 2,389 | $281K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.4% | 10,924 | 10,467 | $248K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 12,430 | 7,476 | $211K |
95 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 1,563 | $137K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 11,721 | $126K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 9,287 | $126K |
| 99401 | 1.1% | 18,461 | $111K | |
| 99381 | <1% | 1,080 | $97K | |
| 99205 | Prolong outpt/office vis | <1% | 669 | $89K |
| 92551 | <1% | 8,675 | $61K | |
| 87807 | <1% | 4,358 | $43K | |
| 97803 | <1% | 21,450 | $38K | |
| 99383 | <1% | 371 | $36K | |
| 99051 | <1% | 17,615 | $35K | |
| 99382 | <1% | 325 | $32K | |
| 69210 | <1% | 825 | $25K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 131 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,393 | $9K |
| 97802 | <1% | 2,282 | $9K | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 10,376 | $9K |
| 99174 | <1% | 4,278 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 841 | $7K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 8,498 | $7K |
| 17250 | <1% | 70 | $4K | |
| 86328 | <1% | 109 | $4K | |
| 99384 | <1% | 30 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 83 | $3K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 8,628 | $2K |
| 83655 | <1% | 131 | $2K | |
| 87428 | <1% | 69 | $2K | |
| 81002 | <1% | 626 | $2K | |
| 99050 | <1% | 273 | $1K | |
| 54450 | <1% | 31 | $1K | |
| 17110 | <1% | 14 | $982.88 | |
| 98966 | <1% | 269 | $866.33 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 106 | $835.70 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 610 | $621.37 |
| 36416 | <1% | 93 | $507.92 | |
| 96127 | <1% | 150 | $433.83 | |
| 94664 | <1% | 38 | $273.50 | |
| 99406 | <1% | 24 | $208.81 | |
| 99000 | <1% | 28 | $196.85 | |
| 99177 | <1% | 41 | $98.70 | |
| 81025 | <1% | 12 | $82.00 | |
| 82150 | <1% | 14 | $79.77 | |
| 90686 | <1% | 969 | $40.14 | |
| 99072 | <1% | 14,457 | $18.00 | |
| 90707 | 0% | 685 | $0.00 | |
| 1032F | 0% | 4,898 | $0.00 | |
| 4025F | 0% | 10,189 | $0.00 | |
| 1033F | 0% | 44,683 | $0.00 | |
| 90710 | 0% | 732 | $0.00 | |
| 90633 | 0% | 1,751 | $0.00 | |
| 99173 | 0% | 2,333 | $0.00 | |
| 90670 | 0% | 2,680 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 34 | $0.00 |
| 1159F | 0% | 53,712 | $0.00 | |
| 4040F | 0% | 44,679 | $0.00 | |
| 1160F | 0% | 53,740 | $0.00 | |
| 3210F | 0% | 1,898 | $0.00 | |
| 90700 | 0% | 910 | $0.00 | |
| 90734 | 0% | 97 | $0.00 | |
| 90461 | 0% | 622 | $0.00 | |
| 3078F | 0% | 461 | $0.00 | |
| 3725F | 0% | 745 | $0.00 | |
| 90648 | 0% | 59 | $0.00 | |
| 90715 | 0% | 194 | $0.00 | |
| 3023F | 0% | 34 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 30 | $0.00 |
| G9002 | Coordinated care fee, maintenance rate | 0% | 12 | $0.00 |
| 1111F | 0% | 17,094 | $0.00 | |
| 90651 | 0% | 389 | $0.00 | |
| 4140F | 0% | 2,850 | $0.00 | |
| 90698 | 0% | 2,541 | $0.00 | |
| 90647 | 0% | 762 | $0.00 | |
| 1036F | 0% | 6,447 | $0.00 | |
| 90680 | 0% | 2,148 | $0.00 | |
| 4037F | 0% | 2,250 | $0.00 | |
| 90744 | 0% | 1,875 | $0.00 | |
| 1000F | 0% | 6,726 | $0.00 | |
| 90696 | 0% | 532 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 411 | $0.00 |
| 1031F | 0% | 57,579 | $0.00 | |
| 90619 | 0% | 249 | $0.00 | |
| 90716 | 0% | 629 | $0.00 | |
| 3044F | 0% | 1,289 | $0.00 | |
| 90677 | 0% | 783 | $0.00 | |
| 3074F | 0% | 464 | $0.00 | |
| 90688 | 0% | 15 | $0.00 | |
| 98967 | 0% | 12 | $0.00 | |
| G9007 | Coordinated care fee, scheduled team conference | 0% | 119 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 133 | $0.00 |
| 90656 | 0% | 58 | $0.00 | |
| 36410 | 0% | 51 | $0.00 | |
| 90723 | 0% | 14 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 35 | $0.00 |
| 90620 | 0% | 17 | $0.00 | |
| 94760 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAWRI, FAISAL (OWNER)
| Provider | Location | Paid |
|---|---|---|
| GB Urgent Care | Grand Blanc, MI | $236K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.